PHIO PHARMACEUTICALS CORP. Operating Lease Cost
PHIO PHARMACEUTICALS CORP. (PHIO) reported Operating Lease Cost of $8.40 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2025-08-14
- PHIO PHARMACEUTICALS CORP. operating lease, cost for the quarter ending 2025-06-30 was $8.40K.
- PHIO PHARMACEUTICALS CORP. operating lease, cost for the quarter ending 2025-03-31 was $8.40K, a 74.55% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. operating lease, cost for the quarter ending 2024-12-31 was $25.00K, a 24.24% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. operating lease, cost for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- PHIO PHARMACEUTICALS CORP. operating lease, cost for fiscal 2024 was $58.00K, a 56.06% decline from fiscal 2023.
- PHIO PHARMACEUTICALS CORP. operating lease, cost for fiscal 2023 was $132.00K, a 0.00% change from fiscal 2022.
- PHIO PHARMACEUTICALS CORP. operating lease, cost for fiscal 2022 was $132.00K, a 0.00% change from fiscal 2021.
- PHIO PHARMACEUTICALS CORP. operating lease, cost for fiscal 2021 was $132.00K, a 99.90% decline from fiscal 2020.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2025-06-30 | $8.40K 10-Q · filed 2025-08-14 | $16.80K 10-Q · filed 2025-08-14 | $41.80K derived: sum of 3 quarters · filed 2025-08-14 | $41.80K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2025-03-31 | $8.40K 10-Q · filed 2025-05-15 | $33.40K derived: sum of 2 quarters · filed 2025-05-15 | $33.40K derived: sum of 3 quarters · filed 2025-05-15 | $33.40K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $25.00K derived: sum of 2 quarters · filed 2025-03-31 | $25.00K derived: sum of 3 quarters · filed 2025-08-14 | $58.00K 10-K · filed 2025-03-31 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2025-08-14 | $33.00K 10-Q · filed 2024-11-14 | $66.00K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-14 | $33.00K 10-Q · filed 2025-08-14 | $66.00K derived: sum of 3 quarters · filed 2025-08-14 | $99.00K derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $33.00K 10-Q · filed 2025-05-15 | $66.00K derived: sum of 2 quarters · filed 2025-05-15 | $99.00K derived: sum of 3 quarters · filed 2025-05-15 | $132.00K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $66.00K derived: sum of 2 quarters · filed 2025-03-31 | $99.00K derived: sum of 3 quarters · filed 2025-03-31 | $132.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $33.00K 10-Q · filed 2024-11-14 | $66.00K derived: sum of 2 quarters · filed 2024-11-14 | $99.00K 10-Q · filed 2024-11-14 | $132.00K derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $33.00K 10-Q · filed 2024-08-14 | $66.00K 10-Q · filed 2024-08-14 | $99.00K derived: sum of 3 quarters · filed 2024-08-14 | $132.00K derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $33.00K 10-Q · filed 2024-05-09 | $66.00K derived: sum of 2 quarters · filed 2024-05-09 | $99.00K derived: sum of 3 quarters · filed 2024-05-09 | $132.00K derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $66.00K derived: sum of 2 quarters · filed 2024-04-01 | $99.00K derived: sum of 3 quarters · filed 2024-04-01 | $132.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $33.00K 10-Q · filed 2023-11-09 | $66.00K derived: sum of 2 quarters · filed 2023-11-09 | $99.00K 10-Q · filed 2023-11-09 | $132.00K derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $33.00K 10-Q · filed 2023-08-10 | $66.00K 10-Q · filed 2023-08-10 | $99.00K derived: sum of 3 quarters · filed 2023-08-10 | $132.00K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $33.00K 10-Q · filed 2023-05-11 | $66.00K derived: sum of 2 quarters · filed 2023-05-11 | $99.00K derived: sum of 3 quarters · filed 2023-05-11 | $132.00K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $66.00K derived: sum of 2 quarters · filed 2023-03-22 | $99.00K derived: sum of 3 quarters · filed 2023-03-22 | $132.00K 10-K · filed 2023-03-22 | $132.00M 10-K · filed 2022-03-22 |
| 2021-09-30 | $33.00K 10-Q · filed 2022-11-10 | $66.00K derived: sum of 2 quarters · filed 2022-11-10 | $99.00K 10-Q · filed 2022-11-10 | $132.00M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $33.00K 10-Q · filed 2022-08-11 | $66.00K 10-Q · filed 2022-08-11 | $131.97M derived: sum of 3 quarters · filed 2022-08-11 | $132.00M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $33.00K 10-Q · filed 2022-05-12 | $131.93M derived: sum of 2 quarters · filed 2022-05-12 | $131.97M derived: sum of 3 quarters · filed 2022-05-12 | $132.00M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $131.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $131.93M derived: sum of 2 quarters · filed 2022-03-22 | $131.97M derived: sum of 3 quarters · filed 2022-03-22 | $132.00M 10-K · filed 2022-03-22 | $132.00K 10-K · filed 2021-03-25 |
| 2020-09-30 | $33.00K 10-Q · filed 2021-11-10 | $66.00K derived: sum of 2 quarters · filed 2021-11-10 | $99.00K 10-Q · filed 2021-11-10 | $132.00K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $33.00K 10-Q · filed 2021-08-12 | $66.00K 10-Q · filed 2021-08-12 | $99.00K derived: sum of 3 quarters · filed 2021-08-12 | $132.00K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $33.00K 10-Q · filed 2021-05-13 | $66.00K derived: sum of 2 quarters · filed 2021-05-13 | $99.00K derived: sum of 3 quarters · filed 2021-05-13 | $132.00K derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $66.00K derived: sum of 2 quarters · filed 2021-03-25 | $99.00K derived: sum of 3 quarters · filed 2021-03-25 | $127.00K 10-K · filed 2021-03-25 | |
| 2019-09-30 | $33.00K 10-Q · filed 2020-11-10 | $66.00K derived: sum of 2 quarters · filed 2020-11-10 | $94.00K 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | $33.00K 10-Q · filed 2020-08-12 | $61.00K 10-Q · filed 2020-08-12 | |||
| 2019-03-31 | $28.00K 10-Q · filed 2020-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |